J. Clark

发表

Osteogenic Sarcoma Associated With Diamond–Blackfan Anemia: A Report From the Diamond–Blackfan Anemia Registry

J. Lipton, C. Schwartz, L. Hilliard, 2001, Journal of pediatric hematology/oncology.

Clinical significance of defective dendritic cell differentiation in cancer.

D. Carbone, S. Nadaf, D. Gabrilovich, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma

C. Hofmeister, B. Emami, G. Petruzzelli, 2001, Cancer.

Phase I Trial of 2B1, a Bispecific Monoclonal Antibody Targeting c-erbB-2 and FcγRIII

L. Weiner, R. Alpaugh, D. Ring, 1995 .

Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients.

M. Young, D. Lathers, J. Clark, 2001, Human immunology.

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.

R. Fisher, J. Sosman, G. Weiss, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry

N. Agarwal, M. Fishman, G. Daniels, 2019, Journal of Immunotherapy for Cancer.

Role of cytokines in pathology of melanoma and use of biologic response modifiers in melanoma.

J. Clark, 2001, Methods in molecular medicine.

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

J. Sosman, G. Weiss, M. Lotze, 2000 .

Metanephric Adenosarcoma in a Young Adult: Morphologic, Immunophenotypic, Ultrastructural, and Fluorescence In Situ Hybridization Analyses: A Case Report and Review of the Literature

J. Eble, M. Picken, Joseph I. Clark, 2001, The American journal of surgical pathology.

A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population.

J. Sosman, T. Kuzel, S. Fisher, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

C. Shapiro, J. Sosman, T. Kuzel, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

J. Sosman, G. Weiss, M. Ernstoff, 2002, Journal of Cancer Research and Clinical Oncology.

Biologic treatment of human cancer.

L. Weiner, J. Clark, 1995, Current problems in cancer.

Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients.

D. Carbone, A. Virmani, S. Chada, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.

B. Emami, G. Petruzzelli, T. Origitano, 2015, American journal of otolaryngology.

Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.

K. Albain, K. Kancharla, A. Hantel, 2001, Lung cancer.

Daily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinoma.

J. Sosman, R. Flanigan, E. Gaynor, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

R. Motzer, M. Michaelson, B. Rini, 2014, British Journal of Cancer.

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.

M. Atkins, D. Quinn, J. Clark, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of Allogeneic Marrow Transplantation in Patients Transplanted for Acute Leukemia: A Long-Term Follow-Up

H. Deeg, N. Flournoy, R. Storb, 1986 .

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

L. Weiner, R. Alpaugh, D. Ring, 1995, Cancer research.

Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

L. Weiner, R. Alpaugh, D. Ring, 1995, Journal of hematotherapy.

Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

S. Litwin, G. Adams, L. Weiner, 1996, Cancer research.

Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma.

K. Albain, J. Clark, 2001, Cancer treatment and research.

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment

J. Gralow, L. Weiner, M. von Mehren, 1997, Cancer Immunology, Immunotherapy.